Davenport Reduces $27M in ESAB Corporation ($ESAB)

Key Points

  • Davenport changed its ESAB Corporation ($ESAB) stake by 30.2% last quarter, cutting to 674,417 shares worth $61.76 million.
  • Wall Street's consensus rating on $ESAB is Strong Buy and an average price target of $136.00.
  • $ESAB last traded around $91.57.

Davenport reduced its position in ESAB Corporation ($ESAB) by 30.2% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 674,417 shares of ESAB Corporation after selling 291,345 shares during the quarter. Davenport's holdings in ESAB Corporation were worth $61.76 million as of its most recent filing.

ESAB Corporation ($ESAB) Stock

Last price$91.57
Market cap$5.57B
P/E ratio24.22
Forward P/E12.95
PEG ratio1.24
Beta1.15
52-week low$82.19
52-week high$137.42
50-day MA$95.86
200-day MA$109.92
Current ratio2.97
Quick ratio2.05
Debt-to-equity0.96

ESAB Corporation Earnings

EPS (ttm)$3.78
Revenue (ttm)$2.91B
Revenue growth9.9%
Net margin7.1%
Return on equity11.4%
Next earningsJul 30, 2026

ESAB Corporation Dividend

Annual dividend$0.42
Dividend yield46.00%
Payout ratio10.6%
Ex-dividend dateJul 2, 2026

Analysts Set New Price Targets

ConsensusStrong Buy
Average target$136.00
High target$154.00
Low target$117.00
Analysts covering9

About ESAB Corporation

ESAB Corporation engages in the formulation, development, manufacture, and supply of consumable products and equipment for use in cutting, joining, automated welding, and gas control equipment. It offers its products through independent distributors and direct salespeople. It operates in Europe, Asia Pacific, South America, and the Middle East. ESAB Corporation was founded in 1904 and is headquartered in North Bethesda, Maryland.

ExchangeNYSE
SectorIndustrials
IndustryMetal Fabrication
HeadquartersNorth Bethesda, MD
Employees10,300

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.